OTC· CIK 0002120882

HXSCL

SK hynix Inc.
—
Snapshot
The big-picture read on HXSCL right now — valuation, ownership and activity at a glance.
SEC Reports
2
Price chart
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Analyst ratings buy % +2.1%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
Sep 1, 2026172920096%
Aug 1, 2026152920096%
Jul 1, 2026143120096%
Jun 1, 2026153120096%
May 1, 2026162830094%
Apr 1, 2026152930094%
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
2 SEC filing reports analyzed · 0 bullish, 1 bearish, 0 mixed, 1 neutral · avg impact 3.0/10.
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Aug 25, 2026
Enforcement
SK hynix Inc. v. BeSang Inc.
Court ruling (ord) — Docket: 3:26-cv-00630
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for HXSCL.
Shares short
1,397
Settlement Sep 15, 2026
Change vs prior
-7.9%
Semi-monthly cycle
All HXSCL filing & press-release reports (2)